Public universities can be negatively affected during a government shutdown — especially within its research department. Miguel Tovar/University of Houston

As the partial government shutdown loomed, academic institutions explored ways this might affect their research operations. Although we expect delays in processing proposals and award payouts, the impact on the institution may have been much less than expected. Consequently, most of the impact occurred at the individual principal investigator, or PI, level. That is where research that required federal resources came to a halt.

This is also the case for researchers at the Borders, Trade, and Immigration (BTI) Institute at the University of Houston. As a result of the shutdown, they were unable to start any new projects. Sadly, the government furloughed their program manager at the Department of Defense- Science and Technology Office of University Programs.

Education initiatives and multiple other research projects pending review were stuck along the "assembly line," as approvals did not happen during the month of January.

Consequently, BTI is a granted institution. Current projects were able to continue with slight delay due to the requirement to have meetings with the DHS representatives for their projects.

This scenario echoed across the research enterprise, as other researchers found themselves in similar situations.

Business as somewhat usual

Moreover, Nicholas Bond, climatologist and associate professor of atmospheric sciences at the University of Washington, felt the pinch of the shutdown and chronicled his experiences of how it impacted his research on climate and oceanography of the North Pacific.

Academic institutions across the country became burdened with the task of assuming unexpected financial responsibilities. In mid-January, the lapse in governmental funding forced The Ohio State University to temporarily cover the costs of unbilled expenditures to the tune of about $3 million. Harvard University continued to pay stipends for fellowships. They did this despite the fact that the shutdown included the federal funding agency.

Many faculty members, including our own, were able to continue working on their projects with the expectation of administrative delays. No new funding opportunities were issued, panel reviews were postponed and no new grants or no-cost extensions were awarded. For the most part, it was business as (somewhat) usual.

The big picture

It may be safe to say that the partial shutdown acted more as an inconvenience to the research enterprise than anything. Which is great news! Especially for the University of Houston, who has recently ignited the campus with the announcement of the 50-in-5 initiative. This ambitious program will increase the research and scholarly output by 50 percent over the next five years.

While this article focuses on the inconvenience of administrative delays, it's critical not to skim the surface. It may seem minute when compared to recipients of public assistance fearing not receiving benefits, but short-term implications are likely.

Keep in mind that most often, grants are not awarded by a single payment from the agency. Timelines are established between agencies and the institutions, and funds are released accordingly. Because of this, it's likely that research programs and educational initiatives across the academic research enterprise will not receive their funds on schedule.

What the future holds

Imagine, if you will, a conveyor belt. A system designed to allow items to move through a process with maximum efficiency. Because of the partial shutdown, research proposals that were in queue for review or funding experienced interruption along the conveyor belt.

Once disruptions to processes within federal agencies happen, it becomes inevitable that there will be delays further down the line.

Claudia Neuhauser, associate vice chancellor/vice president for Research and Technology Transfer for the UH System, warns of the "ripple effect" of the downstream delays and the potential impact on expenditures. We'll have to wait until the end of the year when annual reports are prepared for answers.

For now, it's a question of what the aftereffect will be.

------

This article originally appeared on the University of Houston's The Big Idea.

Nitiya Spearman is the internal communications coordinator for the UH Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston cleantech, space startups named to World Economic Forum cohort

top honor

Two Houston-based startups have been selected to join the World Economic Forum's Technology Pioneers community.

The two-year program aims to help mission-driven, early-stage start-ups scale their innovations through multi-stakeholder initiatives, co-creating partnerships and other gatherings for community members. One-hundred startups are selected each year from around the globe, this year hailing from 23 countries and working in AI, energy, space, biotech markets and more.

Cleantech startup Vaulted Deep was one of 11 energy and climate companies to be named to the cohort. Julia Reichelstein and Omar Abou-Sayed founded the company in 2023. Its technology injects excess organic waste underground to remove carbon dioxide from the atmosphere.

Last year, Vaulted Deep inked a 12-year deal with Microsoft to remove up to 4.9 million metric tons of carbon dioxide from the environment.

The startup has earned several accolades in recent years, including a No. 3 spot on Fast Company’s list of the World’s Most Innovative Companies of 2026. It was also recently named to market intelligence and advisory firm Cleantech Group's annual Global Cleantech 100 list for a second year in a row.

"Waste management is one of the world's great invisible infrastructure systems ... The need for new infrastructure is growing as disposal challenges become more complex and regulations evolve. Vaulted is building the first new disposal pathway for organic waste in decades by putting it deep underground, permanently," the company shared in a LinkedIn post. "This year, we're joining the World Economic Forum's 2026 Tech Pioneers alongside innovators working on the many interconnected challenges shaping our future."

Houston-based Venus Aerospace was also selected to join the cohort, along with six other spacetech companies. The company was founded in 2020 by Sassie and Andrew Duggleby.

The startup specializes in next-generation rocket engine propulsion as a cleaner alternative to traditional combustion engines. The company's rotating detonation rocket engine (RDRE) burns fuel more efficiently and completed a successful high-thrust test flight last year. Venus says it’s the only company in the world that makes a flight-proven, high-thrust RDRE with a “clear path to scaled production.”

"Frontier technologies matter most when they expand what people, industries, and nations can do," Sassie Duggleby, co-founder and CEO of Venus, said in a news release. "For Venus, RDRE does not just represent a more efficient engine. It is a foundation for faster movement, more capable space systems, and new forms of connectivity across the planet. Being named a Technology Pioneer validates the potential of this technology to help shape a future where distance is less limiting."

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston Methodist receives record $110M gift, names future tower

historic gift

Houston Methodist has received the largest gift in the health system's history to establish new funds for neurological, neuroscience, and women’s health research and treatment.

The $110 million gift comes from Houston-based The Brockman Medical Research Foundation, which supports education and research in the science, medicine and healthcare fields. In response, Houston Methodist announced that it will name its forthcoming 26-story hospital facility the Brockman Centennial Tower.

The tower’s entrance will be named the Anna Margaret Bellows Centennial Hall to honor Anna Margaret Bellows, a young camper who died during the Camp Mystic flooding last summer.

“This extraordinary gift accelerates discovery and transforms how care is delivered,” Dr. Marc Boom, president and CEO of Houston Methodist, said in a news release. “We are grateful to The Brockman Medical Research Foundation for its incredible generosity and vision that will help change the lives of generations of patients. Naming Centennial Tower in recognition of this gift reflects the scale of this commitment and its impact on the future of neuroscience, neurological care and women’s health.”

The gift will be divided into two parts:

  • $100 million will go toward creating an innovation fund within the Houston Methodist Academic Institute and the Houston Methodist Neurological Institute
  • $10 million will be devoted to Houston Methodist's Department of Obstetrics and Gynecology

“This tremendous gift will accelerate translational research that broadens our understanding of neurological and other diseases,” Dr. Jenny Chang, president and CEO of the Houston Methodist Academic Institute, added in the release. “It will allow us to leverage state-of-the-art platforms to detect, diagnose and deliver therapeutics, keeping patient care at the center of our mission.”

The Brockman Centennial Tower is expected to open next year in the Texas Medical Center. Spanning more than 1 million square feet, it will house 400 patient beds, an expanded emergency department, new operating rooms and a rooftop garden. It will be connected to Houston Methodist's flagship Paula and Joseph C. “Rusty” Walter III Tower, which opened in 2018. The Centennial Tower was estimated to cost $1.4 billion when announced in 2022.

In addition to the news of the Brockman gift, Houston Methodist also announced this month that it has launched the Houston Methodist Center for Cell and Gene Therapy and tapped an internationally recognized scientist as its leader.

The new center is focused on discovering and developing innovative and cost-effective therapies for a variety of congenital and acquired diseases, including cancer, HIV and cardiovascular disease.

Dr. Malcolm Brenner has been named as the center's inaugural leader and will assume the role starting in October. He will work alongside scientists and support staff from Baylor College of Medicine and Texas Children's Hospital.

Brenner is a professor of pediatrics, medicine, molecular and human genetics and translational biology at Baylor College of Medicine. He is known for making early advances in using bone marrow transplantation as a form of cell therapy and in engineered immune-cell treatments for cancer and infections, according to a release from Houston Methodist.

“Malcolm Brenner is a pioneer in the field of cell and gene therapy and is uniquely qualified to lead Houston Methodist’s research efforts in this field,” Chang added. “His vision and leadership will play a pivotal role in advancing our work in this space.”